Coconote
AI notes
AI voice & video notes
Try for free
Central Nervous System (CNS) Disorders and Medications
Jul 7, 2024
Central Nervous System (CNS) Disorders and Medications
Overview
Topic
: Central nervous system disorders and medications used for treatment.
Focus Areas
: How CNS functions, communication between neurons, definitions, and classifications of CNS disorders.
CNS Communication
Components
: Brain, Spinal Cord, Neurons
Function
: Signal transmission via action potentials (electrical charge) through nerve cells
Movement of sodium and potassium ions creates action potentials
Release of neurotransmitters at synapse
Neurotransmitters
: Chemical messengers released from one neuron to receptor sites on another
Selective release and response by different neurotransmitters and receptor sites
Important Neurotransmitters
GABA
: Inhibitory neurotransmitter; slows down responses creating a calming effect.
Conditions
: Low levels linked to anxiety, seizures, bipolar disorder, impulse control issues.
Serotonin
: Influences mood, sleep, temperature regulation, libido.
Related Medications
: SSRIs (Selective Serotonin Reuptake Inhibitors) for depression.
Dopamine
: Impacts motor responses, cognition, and sympathetic nervous system functions (e.g., blood pressure, heart rate).
Conditions
: ADHD, schizophrenia, Parkinson's disease.
Norepinephrine & Epinephrine
: Sympathetic adrenergic system role, affects alertness, mood, anxiety.
Conditions
: Imbalances can lead to depression, anxiety, panic attacks.
Synaptic Process
Action at Synapse
: Neurotransmitters released from presynaptic neuron to bind on the postsynaptic neuron.
Excess Neurotransmitters
: Diffusion, reuptake by the presynaptic neuron, or breakdown by enzymes (e.g., Monoamine oxidase - MAO)
CNS Disorders and Associated Medication Classes
Anxiety
Description
: Mood and behavior disturbances impacting ADLs.
Symptoms
: Physical issues (aches, GI upset), racing heart, trembling, sweating, difficulty concentrating, emotional disturbances (crying, agitation).
Treatment
: Pharmacological (medications), Non-pharmacological (relaxation techniques, psychotherapy, support groups).
Depression
Description
: Clinical depression involves a collection of 5 or more markers consistently impacting ADLs.
Symptoms
: Suicidal ideation is a major risk; physical, emotional, and psychological markers.
Treatment
: Medications, Psychotherapy, Group Therapy, Electroconvulsive Therapy (ECT).
Bipolar Disorder
Description
: Drastic mood swings between manic and depressive phases.
Symptoms
: Hyperactivity, no need for sleep, mood swings, manic high and depressive low periods.
Treatment
: Medications, Psychotherapy, ECT, Group Therapy.
Schizophrenia
Description
: Breakdown of reality connection; usually appears between ages 15-30.
Symptoms
: Delusions, hallucinations, personal care neglect, energy decrease.
Types of Symptoms
: Positive (delusions, hallucinations), Negative (apathy, lack of motivation), Cognitive (poor decision making, memory loss).
Treatment
: Symptom control, pharmacological and non-pharmacological interventions.
ADHD
Description
: Hyperactivity, inability to concentrate, emotional control issues.
Seizures
Description
: Abnormal neuron activity; hyperexcitable neurons causing massive firing.
Types
:
Partial Seizures
: Simple (one hemisphere, one area affected), Complex (cognitive impairment).
Generalized Seizures
: Involves both hemispheres, affects motor and cognitive functions.
Status Epilepticus
: Continuous seizure activity, life-threatening.
Parkinson's Disease
Description
: Chronic progressive disorder, breakdown of myelin sheath on neurons
Symptoms
: Tremors, slow movement (bradykinesia), shuffling gait, stooped posture, mood swings.
Neurotransmitter Involved
: Dopamine, particularly in extra-pyramidal system.
Treatment
: Focus on dopamine availability and function.
Next Steps
Future videos will discuss individual disorders and related drug classifications for pharmacological treatment.
📄
Full transcript